Latest Data & Signals Issued

Signal Type Signal Value Data
Score -1.709 2 days ( 2.31 % )
Last Price $0.703 -2.31 %
High/ Low $0.700 - $0.714 -3.36%
Chg 7 Days -5.65 % $0.746 $0.703
Chg 30 Days -8.64 % $0.770 $0.703
Chg 12 mos -14.53 % $0.82 $0.703
Trend - 3 mos 17.56 % Width: 46.13 %
Trend - 12 mos 7.93 % Width: 294.01 %
Pred. range - 3 mos $0.779 - $1.14 10.71 % - 61.79 %
Pred. range - 12 mos $0.380 - $1.50 -46.02 % - 112.69 %
Short MA avg 3 mos Buy Jun 24, 2024 - 8 days
Long MA avg 3 mos Sell Jul 01, 2024 - 3 days
Short/Long MA avg 3 mos Buy Jun 04, 2024 - 21 days
Short MA avg 12 mos Sell Jun 25, 2024 - 7 days
Long MA avg 12 mos Sell Jul 01, 2024 - 3 days
Short/Long MA avg 12 mos Buy Feb 21, 2024 - 93 days
Pivot Short Sell Jun 14, 2024 - 13 days
Bollinger Buy Oct 11, 2023 - 183 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Monopar Therapeutics Inc.

Monopar Therapeutics. Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubic... MNPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT